ANI Pharmaceuticals Dismisses EisnerAmper and Appoints Ernst & Young as New Auditor

ANI Pharmaceuticals, Inc. filed a Form 8-K on April 7, 2026, reporting significant changes to its independent registered public accounting firm. On April 1, 2026, the company dismissed EisnerAmper LLP as its auditor, with the dismissal approved by the Audit and Finance Committee. The company simultaneously appointed Ernst & Young LLP as its new independent registered public accounting firm, effective the same day. According to the filing, EisnerAmper's audit reports for fiscal years 2024 and 2025 contained no adverse opinions, disclaimers, or qualifications. There were no disagreements or reportable events between the company and EisnerAmper during the audit periods. The company provided EisnerAmper with a copy of the filing, and EisnerAmper submitted a letter confirming agreement with the statements regarding their dismissal. The auditor change represents a significant corporate governance event for the pharmaceutical company.